Literature DB >> 11714730

Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.

E M Tan1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11714730      PMCID： PMC209427          DOI： 10.1172/JCI14451

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  48 in total

Review 1.  Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

2.  HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal.

Authors:  A Szabo; J Dalmau; G Manley; M Rosenfeld; E Wong; J Henson; J B Posner; H M Furneaux
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

Review 3.  Relation of the hepatitis B virus carrier state to hepatocellular carcinoma.

Authors:  H Popper; D A Shafritz; J H Hoofnagle
Journal:  Hepatology       Date:  1987 Jul-Aug       Impact factor: 17.425

4.  Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.

Authors:  U M Moll; G Riou; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

5.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

6.  Analysis of the anti-p53 antibody response in cancer patients.

Authors:  S Labrecque; N Naor; D Thomson; G Matlashewski
Journal:  Cancer Res       Date:  1993-08-01       Impact factor: 12.701

7.  Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.

Authors:  S F Winter; J D Minna; B E Johnson; T Takahashi; A F Gazdar; D P Carbone
Journal:  Cancer Res       Date:  1992-08-01       Impact factor: 12.701

8.  Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma.

Authors:  H Imai; Y Nakano; K Kiyosawa; E M Tan
Journal:  Cancer       Date:  1993-01-01       Impact factor: 6.860

9.  Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.

Authors:  C Pasquinelli; K Bhavani; F V Chisari
Journal:  Cancer Res       Date:  1992-05-15       Impact factor: 12.701

10.  The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues.

Authors:  J Dalmau; H M Furneaux; C Cordon-Cardo; J B Posner
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307
View more
  81 in total

Review 1.  Serologic laboratory findings in malignancy.

Authors:  Félix Fernández Madrid; Marie-Claire Maroun
Journal:  Rheum Dis Clin North Am       Date:  2011-11       Impact factor: 2.670

Review 2.  Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.

Authors:  E M Tan; F-D Shi
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

3.  Detection of autoantibodies to multiple tumor-associated antigens in the immunodiagnosis of ovarian cancer.

Authors:  Liuxia Li; Kaijuan Wang; Liping Dai; Peng Wang; Xuan-Xian Peng; Jian-Ying Zhang
Journal:  Mol Med Rep       Date:  2008 Jul-Aug       Impact factor: 2.952

4.  Autoimmune Response to IGF2 mRNA-Binding Protein 2 (IMP2/p62) in Breast Cancer.

Authors:  W Liu; Y Li; B Wang; L Dai; W Qian; J-Y Zhang
Journal:  Scand J Immunol       Date:  2015-06       Impact factor: 3.487

5.  Evaluation of serum autoantibody levels in the diagnosis of ovarian endometrioma.

Authors:  Yu-Chiao Yi; Shih-Chi Wang; Chun-Chin Chao; Chia-Ling Su; Yao-Ling Lee; Ling-Yun Chen
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

6.  Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma.

Authors:  Kok Sun Looi; Ernesto S Nakayasu; Raquel A de Diaz; Eng M Tan; Igor C Almeida; Jian-Ying Zhang
Journal:  J Proteome Res       Date:  2008-08-02       Impact factor: 4.466

7.  Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.

Authors:  Xinxin Liu; Yurong Chai; Jitian Li; Pengfei Ren; Mei Liu; Liping Dai; Wei Qian; Wenjie Li; Jian-Ying Zhang
Journal:  Tumour Biol       Date:  2014-01-08

8.  The identification of auto-antibodies in pancreatic cancer patient sera using a naturally fractionated Panc-1 cell line.

Authors:  Chen Li; Hye-Yeung Kim; Huy Vuong; Tasneem Patwa; Manoj Pal; Randall E Brand; Diane M Simeone; David M Lubman
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 9.  FOXOs in cancer immunity: Knowns and unknowns.

Authors:  Youcai Deng; Fangjie Wang; Tiffany Hughes; Jianhua Yu
Journal:  Semin Cancer Biol       Date:  2018-01-05       Impact factor: 15.707

10.  Mining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymoma.

Authors:  Roger R Beerli; Monika Bauer; Andrea Fritzer; Lindsey B Rosen; Regula B Buser; Markus Hanner; Melanie Maudrich; Mario Nebenfuehr; Jorge Alejandro Sepulveda Toepfer; Susanne Mangold; Anton Bauer; Steven M Holland; Sarah K Browne; Andreas Meinke
Journal:  MAbs       Date:  2014       Impact factor: 5.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.